GO TEAM: Glucose Optimization Through Technology Assisted Management
NCT06074458
Summary
Black/African American children and young adults with type 1 diabetes are less likely to use diabetes technologies, such as continuous glucose monitors, insulin pumps, and automated insulin delivery systems, compared to White children and young adults. The investigators are working to find ways to make sure that all patients with type 1 diabetes are equally able to use these technologies. The purpose of this study is to find out if a new computer program for the diabetes team, along with a smartphone app (called Glucosano) for patients/parents, as well as a community health worker, are accepted and used by Black/African American patients and parents living with type 1 diabetes, and if this can help decrease racial disparities in the use of diabetes technologies.
Eligibility
Inclusion Criteria: * Self-reported as Non-Hispanic Black * Clinical diagnosis of T1D requiring treatment with insulin at the time of consent * Not currently (within the past 3 months) using an automated insulin delivery system \\ * Willingness to wear a continuous glucose monitor for 10 days at 3 different time points, and willingness to consider use of a personal continuous glucose monitor Exclusion Criteria: * Clinical diagnosis of Type 2 or monogenic diabetes * Completed high school * Non-English speaking guardians * Automated insulin delivery system use within the past 3 months * Custody of children and family services
Conditions2
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06074458